Rudolf Then
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus
- HIV/AIDS drug development and treatment
Papers in
-
- Antibiotic Resistance in Bacteria 22
-
- Antimicrobial Resistance in Staphylococcus 9
- HIV/AIDS drug development and treatment 9
- Co-authors
- Peter AngehrnI. KompišMalcolm G. P. PageKhalid IslamDietrich StüberGlenn E. DaleP. HohlHans H. Locher
- Journals
- Antimicrobial Agents and Chemotherapy (10 papers)The Journal of Antibiotics (6 papers)Clinical Infectious Diseases (4 papers)Journal of Chemotherapy (4 papers)Chemotherapy (3 papers)
- Partner nations
- SwitzerlandGermanyJapan
In The Last Decade
Rudolf Then
68 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 96
- Molecular Medicine 565
- Infectious Diseases 629
- Applied Microbiology and Biotechnology 57
- Pharmacology 400
- Clinical Biochemistry 143
Countries citing papers authored by Rudolf Then
This map shows the geographic impact of Rudolf Then's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rudolf Then with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rudolf Then more than expected).
Fields of papers citing papers by Rudolf Then
This network shows the impact of papers produced by Rudolf Then. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rudolf Then. The network helps show where Rudolf Then may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rudolf Then, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 79 | |
| 2 | 2005 | 182 | |
| 3 | 1997 | 152 | |
| 4 | 1997 | 130 | |
| 5 | 1995 | 7 | |
| 6 | 1994 | 4 | |
| 7 | 1993 | 4 | |
| 8 | 1992 | 35 | |
| 9 | 1992 | 3 | |
| 10 | 1992 | 15 | |
| 11 | 1990 | 24 | |
| 12 | 1989 | 21 | |
| 13 | 1988 | 6 | |
| 14 | 1987 | 22 | |
| 15 | 1980 | 1 | |
| 16 | Neisseriaceae, a group of bacteria with dihydrofolate reductases, moderately susceptible to trimethoprim. | 1979 | 1 |
| 17 | 2 4 di amino 5 pyridylmethyl pyrimidine as potential chemo therapeutics | 1977 | 3 |
| 18 | 1977 | 94 | |
| 19 | Influence of sulfonamide antagonists on the synergism of sulfamethoxazole-trimethoprim in Escherichia coli. | 1973 | 2 |
| 20 | 1972 | 2 |
About Rudolf Then
Rudolf Then is a scholar working on Molecular Medicine, Infectious Diseases, Pharmacology, Organic Chemistry and Epidemiology, having authored 68 papers that have together received 1.8k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (22 papers), Pneumocystis jirovecii pneumonia detection and treatment (17 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Antimicrobial Resistance in Staphylococcus (9 papers), HIV/AIDS drug development and treatment (9 papers), Synthesis of β-Lactam Compounds (8 papers), Biochemical and Molecular Research (6 papers) and Pharmaceutical and Antibiotic Environmental Impacts (6 papers). The work is most often cited by research in Molecular Medicine (565 citations), Infectious Diseases (629 citations), Applied Microbiology and Biotechnology (57 citations), Pharmacology (400 citations) and Clinical Biochemistry (143 citations). Rudolf Then has collaborated with scholars based in Switzerland, Germany and Japan. Frequent co-authors include Peter Angehrn, I. Kompiš, Malcolm G. P. Page, Khalid Islam, Dietrich Stüber, Glenn E. Dale, P. Hohl, Hans H. Locher, Paul Hebeisen and Peter Hartman. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Journal of Antibiotics, Clinical Infectious Diseases, Journal of Chemotherapy and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.